Protein kinase C activation enhances morphine-induced rapid desensitization of μ-opioid receptors in mature rat locus ceruleus neurons

Molecular Pharmacology

Volumn 66, Issue 6, 2004, Pages 1592-1598

  Bailey, Christopher P ^a   Kelly, Eamonn ^a   Henderson, Graeme ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CHELERYTHRINE; G PROTEIN COUPLED RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; PHORBOL ESTER; POTASSIUM CHANNEL; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

AGONIST; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ENZYME ACTIVATION; LOCUS CERULEUS; MALE; MORPHINE TOLERANCE; NERVE CELL; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; KINETICS; LOCUS COERULEUS; MALE; MEMBRANE POTENTIALS; MORPHINE; NEURONS; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M3; RECEPTORS, OPIOID, MU; TETRADECANOYLPHORBOL ACETATE;

EID: 9444274109     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.004747     Document Type: Article

References (47)

1. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, von Zastrow M, Grandy DK, and Williams JT (2002) Mu-opioid receptors: ligand-dependent activation of potassium conductance, desensitization and internalization. J Neurosci 22:5769-5776.
2. Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, and Henderson G (2003) Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. J Neurosci 23:10515-10520.
3. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, and Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature (Lond) 408:720-723.
4. Bohn LM, Lefkowitz RJ, and Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 22:10494-10500.
5. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, and Lin F-T (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science (Wash DC) 286:2495-2498.
6. Borgland SL, Connor M, Osborne PB, Furness JB, and Christie MJ (2003) Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization and endocytosis of μ-opioid receptors. J Biol Chem 278:18776-18784.
7. Caruso FS (2000) MorphiDex pharmacokinetic studies and single-dose analgesic efficacy studies in patients with postoperative pain. J Pain Symptom Manage 19:S31-S36.
8. Celver J, Xu M, Jin W, Lowe J, and Chavkin C (2004) Distinct domains of the μ-opioid receptor control uncoupling and internalization. Mol Pharmacol 65:528-537.
9. Chakrabarti S and Gintzler AR (2003) Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity. Mol Brain Res 119:144-151.
10. Christie MJ, Williams JT, and North RA (1987) Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol Pharmacol 32:633-638.
11. Chuang TT, LeVine H III, and De Blasi A (1995) Phosphorylation and activation of β-adrenergic receptor kinase by protein kinase C. J Biol Chem 270:18660-18665.
12. Dang VC and Williams JT (2004) Chronic morphine treatment reduces recovery from opioid desensitization. J Neurosci 24:7699-7706.
13. Egan TM and North RA (1985) Acetylcholine acts on M2-muscarinic receptors to excite rat locus coeruleus neurones. Br J Pharmacol 85:733-735.
14. Finn AK and Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829-839.
15. Fiorillo CD and Williams JT (1996) Opioid desensitization: interactions with G-protein-coupled receptors in the locus coeruleus. J Neurosci 16:1479-1485.
16. Granados-Soto V, Kalcheva I, Hua X-Y, Newton A, and Yaksh TL (2000) Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain 85:395-404.
17. Haberstock-Debic H, Wein M, Barrot M, Colago EEO, Rahman Z, Neve RL, Pickel VM, Nestler EJ, von Zastrow M, and Svingos AL (2003) Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J Neurosci 23:4324-4332.
18. Hua XY, Moore A, Malkmus S, Murray SF, Dean N, Yaksh TL, and Butler M (2002) Inhibition of spinal protein kinase Calpha expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance. Neuroscience 113:99-107.
19. Huang CL, Feng S, and Hilgemann DW (1998) Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature (Lond) 391:803-806.
20. Inoue M and Ueda H (2000) Protein kinase C-mediated acute tolerance to peripheral μ-opioid analgesia in the bradykinin-nociception test in mice. J Pharmacol Exp Ther 293:662-669.
21. Kohout TA and Lefkowitz RJ (2003) Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol 63:9-18.
22. Kovoor A, Celver JP, Wu A, and Chavkin C (1998) Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol Pharmacol 54:704-711.
23. Krupnick JG and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
24. + channels. J Biol Chem 270:28660-28667.
25. Liu J-G and Anand KJS (2001) Protein kinases modulate the cellular adaptations associated with tolerance and dependence. Brain Res Rev 38:1-19.
26. Malenka RC, Madison DV, and Nicoll RA (1986) Potentiation of synaptic transmission in the hippocampus by phorbol esters. Nature (Lond) 321:175-177.
27. Mandyam CD, Thakker DR, Christensen JL, and Standifer KM (2002) Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and μ opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk. J Pharmacol Exp Ther 302:502-509.
28. Mao J, Price DD, and Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259-274.
29. + channels by protein kinase C. Proc Natl Acad Sci USA 101:1087-1092.
30. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, et al. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature (Lond) 383:819-823.
31. Narita M, Ohsawa M, Mizoguchi H, Kamei J, and Tseng LF (1997) Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by μ- but not ε-opioid receptor agonist in the mouse. Neuroscience 76:291-298.
32. Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science (Wash DC) 278:58-62.
33. North RA and Williams JT (1985) On the potassium conductance increased by opioids in rat locus coeruleus neurones. J Physiol 364:265-280.
34. North RA, Williams JT, Surprenant A, and Christie MJ (1987) μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84:5487-5491.
35. Popik P, Kozela E, and Pilc A (2000) Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. Br J Pharmacol 130:1425-1431.
36. Powell KJ, Quirion R, and Jhamandas K (2003) Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons. Eur J Neurosci 18:1572-1583.
37. Shen KZ and North RA (1992) Muscarine increases cation conductance and decreases potassium conductance in rat locus coeruleus neurones. J Physiol 455: 471-485.
38. Thakker DR and Standifer KM (2002) Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between μ and ORL1 receptors following prolonged agonist exposure. Neuropharmacology 43:979-990.
39. Trujillo KA and Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (Wash DC) 251:85-87.
40. Ueda H, Inoue M, and Matsumoto T (2001) Protein kinase C-mediated inhibition of μ-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral μ-agonist analgesia. J Neurosci 21:2967-2973.
41. Watkins LR, Kinscheck IB, and Mayer DJ (1984) Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science (Wash DC) 224:395-396.
42. Whistler JL, Chuang HH, Chu P, Jan LY, and von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
43. Winstel R, Freund S, Krasel C, Hoppe E, and Lohse MJ (1996) Protein kinase cross-talk: membrane targeting of the β-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci USA 93:2105-2109.
44. Yang C and Kazanietz MG (2003) Divergence and complexities in DAG signaling: looking beyond PKC. Trends Pharmacol Sci 24:602-608.
45. Zeitz KP, Malmberg AB, Gilbert H, and Basbaum AI (2001) Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice. Pain 102:245-253.
46. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.
47. Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, and Wang JB (1996) Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 271:11449-11454.